These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2861888)

  • 21. Plasma free 3-methoxy-4-hydroxyphenylglycol in acute schizophrenics before and after treatment.
    Kaneko M; Honda K; Kanno T; Horikoshi R; Manome T; Watanabe A; Kumashiro H
    Neuropsychobiology; 1992; 25(3):126-9. PubMed ID: 1357582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic plasma levels.
    Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N
    Schizophr Bull; 1991; 17(2):197-216. PubMed ID: 1679251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R; Angrist B; Peselow E; Cooper T; Rotrosen J
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The "the therapeutic window" of neuroleptic levels in the erythrocytes of schizophrenics (proceedings)].
    Yesavage JA
    Ann Med Psychol (Paris); 1979; 137(3-4):251. PubMed ID: 40511
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs.
    Emrich HM; Höllt V; Bergmann M; Kissling W; Schmid W; Zerssen DV; Herz A
    Adv Biochem Psychopharmacol; 1980; 22():489-502. PubMed ID: 6104902
    [No Abstract]   [Full Text] [Related]  

  • 27. Risperidone plasma levels, clinical response and side-effects.
    Riedel M; Schwarz MJ; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
    Kolakowska T; Fraser S; Franklin M; Knox J
    Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia.
    Gaebel W; Müller-Oerlinghausen B; Schley J
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):891-900. PubMed ID: 1355303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
    Akiyama K; Tsuchida K; Kanzaki A; Ujike H; Hamamura T; Kondo K; Mutoh S; Miyanagi K; Kuroda S; Otsuki S
    Biol Psychiatry; 1995 Nov; 38(10):639-48. PubMed ID: 8555375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.
    Shriqui CL
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S38-48. PubMed ID: 8564916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
    Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
    Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels.
    Chetty M; Pillay VL; Moodley SV; Miller R
    Eur Neuropsychopharmacol; 1996 May; 6(2):85-91. PubMed ID: 8791032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the clinical utility of radioreceptor assay in outpatients with schizophrenia receiving high doses of neuroleptics.
    Gagné MA; Cormier H; Leblanc G; Lévesque D; Di Paolo T
    Can J Psychiatry; 1993 Oct; 38(8):534-40. PubMed ID: 7902199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3H-spiperone binding to lymphocytes in neuroleptic-naive-schizophrenia and the effect of neuroleptic treatment.
    Laufer N; Spivak B; Holdengreber V; Zipser J; Kosower N; Ragolsky M; Weizman A
    Clin Neuropharmacol; 1999; 22(2):110-4. PubMed ID: 10202608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluphenazine activity and antipsychotic response.
    Hitzemann RJ; Garver DL; Mavroidis M; Hirschowitz J; Zemlan FP
    Psychopharmacology (Berl); 1986; 90(2):270-3. PubMed ID: 3097710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic prescription for Chinese schizophrenics in Hong Kong.
    Chiu H; Lee S; Leung CM; Wing YK
    Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
    Lingjaerde O
    Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.